We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+7.35%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$438M
AUM Growth
+$79M
Cap. Flow
+$165M
Cap. Flow %
37.75%
Top 10 Hldgs %
55.67%
Holding
153
New
56
Increased
27
Reduced
23
Closed
42

Top Buys

Rank Stock Value
1
SMMF
Summit Financial Group, Inc.
SMMF
+$111M
2
NVS icon
Novartis
NVS
+$41.1M
3
RDHL
Redhill Biopharma
RDHL
+$23M
4
JNJ icon
Johnson & Johnson
JNJ
+$20M
5
LLY icon
Eli Lilly
LLY
+$16.7M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$9.18M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$7.75M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$7.1M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.09M
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$3.12M

Sector Composition

Rank Sector Weight
1 Healthcare 73.63%
2 Consumer Discretionary 3%
3 Technology 2.66%
4 Industrials 1.84%
5 Consumer Staples 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVS icon
1
Novartis
NVS
$297B
$45.4M 10.37%
597,172
+563,692
+1,684% +$41.1M
GSK icon
2
GSK
GSK
$104B
$34.7M 7.93%
520,000
+80,000
+18% +$5.41M
SNY icon
3
Sanofi
SNY
$103B
$33.4M 7.62%
+320,000
New +$16.2M
MRK icon
4
Merck
MRK
$322B
$30.1M 6.87%
555,440
+262,000
+89% +$13.6M
PFE icon
5
Pfizer
PFE
$143B
$27.4M 6.27%
900,744
+160,313
+22% +$4.78M
JNJ icon
6
Johnson & Johnson
JNJ
$618B
$22M 5.01%
223,600
+215,800
+2,767% +$20M
LLY icon
7
Eli Lilly
LLY
$1.02T
$17.7M 4.03%
+300,000
New +$16.7M
XLF icon
8
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$15.2M 3.47%
775,370
-93,634
-11% -$1.79M
XLV icon
9
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$9.32M 2.13%
159,353
+23,330
+17% +$1.34M
AMGN icon
10
Amgen
AMGN
$208B
$8.63M 1.97%
70,000
– –
GILD icon
11
Gilead Sciences
GILD
$162B
$6.66M 1.52%
94,000
– –
SGEN
12
DELISTED
Seagen Inc. Common Stock
SGEN
$5.82M 1.33%
127,800
+5,000
+4% +$239K
PRGO icon
13
Perrigo
PRGO
$1.4B
$5.58M 1.27%
+36,106
New +$5.7M
BIIB icon
14
Biogen
BIIB
$30B
$5.2M 1.19%
17,000
+5,000
+42% +$1.59M
UTHR icon
15
United Therapeutics
UTHR
$25.8B
$4.7M 1.07%
+50,000
New +$5.11M
TJX icon
16
TJX Companies
TJX
$174B
$4.54M 1.04%
149,832
+19,400
+15% +$587K
INCY icon
17
Incyte
INCY
$24.2B
$4.44M 1.01%
83,000
-47,000
-36% -$2.92M
CL icon
18
Colgate-Palmolive
CL
$73.1B
$4.07M 0.93%
62,799
+9,500
+18% +$599K
NKE icon
19
Nike
NKE
$61.9B
$3.66M 0.84%
99,088
+69,100
+230% +$2.61M
XNTK icon
20
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
$3.62M 0.83%
+5,600
New +$255K
XLE icon
21
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$3.56M 0.81%
+80,000
New +$3.45M
BRCM
22
DELISTED
BROADCOM CORP CL-A
BRCM
$3.54M 0.81%
112,500
+16,500
+17% +$497K
FEZ icon
23
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.42B
$3.54M 0.81%
+83,000
New +$3.44M
ORBK
24
DELISTED
Orbotech Ltd
ORBK
$3.44M 0.78%
223,174
+16,420
+8% +$229K
WBA
25
DELISTED
Walgreens Boots Alliance
WBA
$3.4M 0.78%
51,453
+16,153
+46% +$1.02M
1
2 3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2014 Portfolio in Review

As of Q1 2014, Sphera Funds Management held 153 positions worth $438M, up 22% from $359M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sphera Funds Management deployed $165M of net new capital in Q1 2014, opening 56 new positions and adding to 27 existing holdings. Its largest new stake was Summit Financial Group, Inc.: 10,921,656 shares worth $1.75M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $4.09M trimmed.

  • Sphera Funds Management's largest Q1 2014 buy was Summit Financial Group, Inc.: 10,921,656 shares worth $1.75M.
  • Sphera Funds Management added most to Novartis in Q1 2014, an estimated $41.1M increase.
  • Sphera Funds Management's biggest Q1 2014 reduction was Teva Pharmaceuticals, cutting an estimated $4.09M.
  • Sphera Funds Management fully exited Shire pic in Q1 2014, selling an estimated $9.18M.
  • Sphera Funds Management's ten largest holdings make up 56% of its $438M portfolio in Q1 2014.
  • Sphera Funds Management opened 56 new positions and closed 42 in Q1 2014.
  • Sphera Funds Management's portfolio value rose 22% quarter-over-quarter to $438M.

Based on Sphera Funds Management's 13F filing for Q1 2014, filed 14 May 2014.